Vitamin B12, Iron, Vitamin A and Iodine: study protocols
6 study groups took Vitamin B12 together with Iron, Vitamin A and Iodine. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin B12
6 study groups in 6 studies say how much Vitamin B12 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2.5 mcg to 5 mcg, 50% of 6 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mcg or less | 1 |
| 1 mcg to 2.5 mcg | 1 |
| 2.5 mcg to 5 mcg | 3 |
| 5 mcg to 10 mcg | 0 |
| 10 mcg to 25 mcg | 0 |
| 25 mcg to 50 mcg | 0 |
| 50 mcg to 100 mcg | 1 |
Dose per serving from research: Iron
6 study groups in 6 studies say how much Iron participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 mg to 50 mg, 50% of 6 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg to 10 mg | 2 |
| 10 mg to 25 mg | 1 |
| 25 mg to 50 mg | 3 |
Dose per serving from research: Vitamin A
5 study groups in 5 studies say how much Vitamin A participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 500 mcg to 1 mg, 60% of 5 study groups.
| Daily dose | Study groups |
|---|---|
| 250 mcg to 500 mcg | 2 |
| 500 mcg to 1 mg | 3 |
Dose per serving from research: Iodine
6 study groups in 6 studies say how much Iodine participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mcg to 250 mcg, 83% of 6 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg or less | 1 |
| 100 mcg to 250 mcg | 5 |
Commonly used together
6 of 6 study groups took Vitamin B12, Iron, Vitamin A and Iodine with something else. Shown: what 3 or more different studies gave. The 10 most common of 11.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Selenium | 6 |
| Vitamin E | 6 |
| Zinc | 6 |
| Copper | 5 |
| Folic Acid | 4 |
| Riboflavin | 4 |
| Vitamin B6 | 4 |
| Vitamin C | 4 |
| Vitamin D | 4 |
| Niacin | 3 |
6 study groups
| Study | ||||||
|---|---|---|---|---|---|---|
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 2 mcg | 18 mg | 1 mg | 150 mcg | 335 days | — |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh | 2.6 mcg | 27 mg | 770 mcg | 220 mcg | 165 days | 749 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 2.6 mcg | 27 mg | 770 mcg | 220 mcg | — | 176 |
| Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial 2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies | 0.9 mcg | 6 mg | 400 mcg | 90 mcg | 36 weeks | 130 |
| Assessment of vitamin A, vitamin B(2), vitamin B(12), vitamin K, folate, and choline status following 4 months of multinutrient supplementation in healthy vegans: a randomised, double-blind, placebo-controlled trial 2025 · INT (intervention group; standard and double omega-3 dosage subgroups) · Healthy adults aged 18 years or older who had followed a vegan diet for at least 1 year; no diagnosed vitamin or mineral deficiency | 100 mcg | 6 mg | 500 mcg | 150 mcg | 120 days | 35 |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 2.6 mcg | 30 mg | — | 150 mcg | 12 weeks | 105 |